Scientists test new prostate cancer imaging drug against existing option
NCT ID NCT06516510
Summary
This early study compared two radioactive drugs used to image and treat prostate cancer that has spread. Seventeen men with advanced prostate cancer received both drugs in a random order. Researchers measured how much radiation reached tumors versus healthy organs like kidneys to see if one drug might be safer or more effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Biogenix Molecular LLC
Miami, Florida, 33165, United States
-
Centro Integral Oncologico Clara Campal
Madrid, Madrid, 28050, Spain
-
Clinica Universidad de Navarra
Madrid, 28027, Spain
-
Clinica Universidad de Navarra - Pamplona
Pamplona, Navarre, 31008, Spain
-
Emory University Hospital
Atlanta, Georgia, 30322, United States
-
Radboud UMC
Nijmegen, Gelderland, 6525GA, Netherlands
Conditions
Explore the condition pages connected to this study.